Corrigendum to “Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC” [Photodiagnosis and Photodynamic Therapy. 37 (2022) 102572]

IF 2.6 3区医学 Q2 ONCOLOGY

Photodiagnosis and Photodynamic Therapy Pub Date : 2025-08-01 DOI:10.1016/j.pdpdt.2025.104657

Ting Lv , Jianhua Huang , Minfeng Wu , Hongwei Wang , Qingyu Zeng , Xiuli Wang

引用次数: 0

查看原文本刊更多论文

“Halofuginone通过抑制cSCC中NRF2信号传导来增强ALA-PDT的抗肿瘤作用”的更正[Photodiagnosis and Photodynamic Therapy. 37(2022) 102572]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Photodiagnosis and Photodynamic Therapy ONCOLOGY-

CiteScore

5.80

自引率

24.20%

发文量

509

审稿时长

50 days

期刊介绍： Photodiagnosis and Photodynamic Therapy is an international journal for the dissemination of scientific knowledge and clinical developments of Photodiagnosis and Photodynamic Therapy in all medical specialties. The journal publishes original articles, review articles, case presentations, "how-to-do-it" articles, Letters to the Editor, short communications and relevant images with short descriptions. All submitted material is subject to a strict peer-review process.